COCP today
$1.02-$0.01 (-0.97%)close Nov 11, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bearish
1 hourStrong Bearish
15 minLeaning Bearish
5 minConsolidating
Daily trend turns down below $0.86
Key levels
Resistance$1.14
Resistance$1.06
Support$0.98
Support$0.91
Latest news & SEC filings
ProductCocrystal Pharma completes dosing in Phase 1b norovirus study of CDI-988
All COCP news →About Cocrystal Pharma
Cocrystal Pharma develops antiviral drugs and is still in the clinical testing phase of its work. It designs small molecule therapies aimed at RNA viruses such as influenza, norovirus, coronaviruses, and hepatitis C. Its lead candidates include CC-42344 for influenza, CDI-988 for norovirus and coronaviruses, and CC-31244 for hepatitis C. The company carries out its activities in the United States and the United Kingdom.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
Cocrystal Pharma, Inc. (COCP)
What Is the Price Target for COCP?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is COCP a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for COCP.
Start Free Trial →Is COCP Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B
Fair Value
$1.06
12
Moat Score
NONE
2/9
Piotroski Score
-49.4
Altman Z-Score
What Is Smart Money Doing with COCP?
Insider Signal
NEUTRAL
2 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →COCP Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
54.65%
FCF Growth YoY
50.3%
Revenue Trend
UNKNOWN
Dark Pool Trades for COCP
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for COCP, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:07:49 | $1.03 | 2,947 | $$3K | SELL |
| 19:30:42 | $1.03 | 1,000 | $$1K | MIDPOINT |
| 19:00:46 | $1.03 | 2,104 | $$2K | SELL |
| 15:05:39 | $1.01 | 1,030 | $$1K | SELL |
| 16:59:45 | $1.03 | 5,000 | $$5K | SELL |
5 dark pool trades shown · $$12K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Cocrystal Pharma, Inc. (COCP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →COCP — frequently asked questions
What is COCP stock price today?
Cocrystal Pharma, Inc. (COCP) is at $1.02, down 0.97% (-$0.01) at the Nov 11, 2026 close.
Why is COCP stock moving today?
Latest COCP news — Sep 9, 2026: Cocrystal Pharma completes dosing in Phase 1b norovirus study of CDI-988
What do analysts rate COCP?
Analyst ratings for COCP: 1 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did COCP beat earnings?
COCP last reported on Aug 13, 2026: EPS -$0.23 vs -$0.17 expected — a miss of 39.4%.
Does COCP pay a dividend?
COCP does not currently pay a dividend.
What are COCP support and resistance levels?
Support: $0.98, $0.91. Resistance: $1.06, $1.14, $1.28.
What are insiders doing with COCP?
Insider activity: NEUTRAL, 2 buys and 0 sells in the last 90 days.
What is the latest news on COCP?
Sep 9, 2026: Cocrystal Pharma completes dosing in Phase 1b norovirus study of CDI-988